Merz Aesthetics Launches Ultherapy PRIME: The Next Generation of Nonsurgical Skin Lifting

Merz Aesthetics, the global leader in medical aesthetics, has announced the launch of Ultherapy PRIME, the latest evolution in nonsurgical skin lifting treatments. FDA-cleared and designed to deliver personalized, long-lasting skin lifting with zero downtime, Ultherapy PRIME builds on the success of the original Ultherapy® platform, renowned as the Gold Standard for nonsurgical lifting.

Ultherapy PRIME introduces advanced ultrasound technology with real-time imaging, offering healthcare professionals faster treatments and enhanced precision. Its updated design includes a 35% larger screen, a faster image refresh rate, and improved ergonomics, providing better visualization and more efficient workflows.

Bob Rhatigan, CEO of Merz Aesthetics, stated, “Ultherapy PRIME reflects our commitment to continuous innovation. As a leader in noninvasive lifting, we are excited to offer our customers this premier platform, combining proven results with customizable treatment options.”

Targeting collagen and elastin-rich layers, Ultherapy PRIME stimulates the natural production of collagen, delivering a personalized lift that can last up to a year or more. With more than three million Ultherapy treatments performed globally, the platform safely lifts the skin on the brows, chin, and neck, while reducing lines and wrinkles on the décolleté. The platform’s 95% patient satisfaction rate and its foundation in over 120 publications and 56 clinical studies reinforce its reputation for effective and safe outcomes.

Dr. Sabrina Fabi, a renowned board-certified dermatologist, emphasized the importance of Ultherapy PRIME in addressing the diverse skin needs of patients. “Ultherapy PRIME offers significant advancements in noninvasive lifting while improving skin quality. It is an ideal solution for those seeking a younger, healthier appearance in just one session without downtime.”